Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
16
NCT03976076
A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 15, 2020
Completion: Dec 10, 2021